Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea

Immunogenicity and safety of a split-virion quadrivalent influenza vaccine in adults 18–60 years of age in the Republic of Korea

VaxigripTetra® (Sanofi Pasteur, Lyon, France) is a quadrivalent split-virion inactivated influenza vaccine (IIV4) containing two B-lineage strains approved in the European Union and Taiwan in 2016 for individuals ≥ 3 years of age. Here, we describe an observer-blind, randomized, controlled, multicen...

Full description

Bibliographic Details
Main Authors: Won Suk Choi, Ji Yun Noh, Jacob Lee, Jun Yong Choi, Jin-Soo Lee, Moo Soo Kim, Hee Soo Kim, Joon Bang, Nathalie Lavis, Woo Joo Kim
Format: Article
Language:English
Published: Taylor & Francis Group 2018-03-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
quadrivalent influenza vaccine
inactivated influenza vaccine
adults
republic of korea
Online Access:http://dx.doi.org/10.1080/21645515.2017.1381808

Internet

http://dx.doi.org/10.1080/21645515.2017.1381808

Similar Items